<DOC>
	<DOC>NCT01857206</DOC>
	<brief_summary>Evaluate safety and tolerability of TIVa or TIVb vaccine in healthy children and adolescents 4 to 17 years of age.</brief_summary>
	<brief_title>Safety of Two Trivalent Influenza Vaccines Evaluated in Children and Adolescents 4 to 17 Years of Age</brief_title>
	<detailed_description />
	<mesh_term>Influenza, Human</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Healthy subjects 417 years of age Subjects who are not healthy, Subjects who are pregnant or breast feeding, Subjects with a history of severe allergic reaction or allergic to any of the vaccine components.</criteria>
	<gender>All</gender>
	<minimum_age>4 Years</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>November 2014</verification_date>
	<keyword>Influenza</keyword>
	<keyword>children and adolescents</keyword>
	<keyword>trivalent vaccine</keyword>
	<keyword>cell culture</keyword>
	<keyword>embryonated chicken eggs</keyword>
</DOC>